Goodluck Lyatuu
Affiliated to Research
E-mail: goodluck.lyatuu@ki.se
Visiting address: Widerströmska huset Tomtebodavägen 18 A, plan 3, 17165 Solna
Postal address: K9 Global folkhälsa, K9 GPH Ekström, 171 77 Stockholm
About me
- I am a medical doctor and public health specialist at Management and
Development for Health (MDH) in Dar es Salaam, Tanzania. For the most of my
career, my work has mainly centered on reproductive, maternal, newborn and
child health (RMNCH) and Infectious Diseases. These two areas remain among
major health challenges in sub-Saharan Africa (SSA) and many other developing
countries. My career motivation is to lead efforts, build networks and
collaborate to bridge the gap in research, practice and health outcomes by
generating, sharing and applying scientific evidence to address health
challenges in Tanzania, SSA and the world at large. As a PhD candidate at KI,
my research is focused on investigating the effect of the World Health
Organization (WHO)'s Option B+ intervention in the prevention of mother to
child transmission of HIV (PMTCT) in routine care settings. (more information
below)
Henry Masters Award –The Dartmouth Institute, For exemplifying Henry’s
spirit and passion, for continuing Henry’s bright light full of passion,
intelligence and compassion, and for caring deeply about making a difference
in health care through social change, Dartmouth College, Hanover, NH
Research Capstone Award - The Dartmouth Institute, For exemplary achievement
on the 2013 Capstone Project titled, “The effect of high-protein energy
supplementation on disease progression among non-malnourished HIV-infected
children 1-5 years old in resource limited settings”, Dartmouth College,
Hanover, NH
PhD Candidate 2020 (Karolinska Institutet, Stockholm, Sweden) MPH 2013
(Geisel School of Medicine at Dartmouth, Hanover, USA) MD 2009 (Muhimbili
University, Dar es Salaam, Tanzania)
Research
- The World Health Organization (WHO)'s Option B+, entailing provision of
lifelong antiretroviral therapy (ART) for all pregnant and breastfeeding
women, has become the mainstay intervention for prevention of mother to child
transmission of HIV (PMTCT) globally. This was in part motivated by
compelling evidence from clinical trials on it's success in PMTCT . My PhD
research is focused on answering three main questions: 1) How well does
Option B+ work in routine care settings? 2) What influences it's success in
these settings? 3) How can we optimize Option B+ service delivery to achieve
maximum benefits from it? The research is based in Dar es Salaam, Tanzania
Articles
- Article: JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. 2024;27(2):e26186
- Article: THE LANCET HIV. 2023;10(1):e33-e41
- Article: THE LANCET GLOBAL HEALTH. 2022;10(11):e1646-e1654
- Article: PLOS GLOBAL PUBLIC HEALTH. 2022;2(3):e0000256
- Article: MEDICINE (UNITED KINGDOM). 2021;100(46):e27828
- Article: INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH. 2021;18(11):6052
- Article: THE LANCET HIV. 2020;7(2):E129-E140
- Article: PLOS ONE. 2018;13(12):e0207986
- Article: BMC PREGNANCY AND CHILDBIRTH. 2016;16:236
- Article: REPRODUCTIVE HEALTH. 2016;13(1):79
- Article: PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2014;33(12):1234-1236
- Article: JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (1999). 2014;67(Suppl 4):S228-S234
- Article: INTERNATIONAL JOURNAL OF MATERNAL AND CHILD HEALTH AND AIDS. 2014;2(2):220-228
- Article: NARRATIVE INQUIRY IN BIOETHICS. 2012;2(2):75-78